Brown JD - Search Results

1

Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.

Brown JD, Shewale AR, Dherange P, Talbert JC. Brown JD, et al. J Am Coll Cardiol. 2016 Dec 6;68(22):2492. doi: 10.1016/j.jacc.2016.06.082. J Am Coll Cardiol. 2016. PMID: 27908358 Free article. No abstract available.

2

A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras.

Brown JD, Shewale AR, Dherange P, Talbert JC. Brown JD, et al. Drugs Aging. 2016 Jun;33(6):427-36. doi: 10.1007/s40266-016-0369-y. Drugs Aging. 2016. PMID: 27154397

3

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.

Brown JD, Shewale AR, Talbert JC. Brown JD, et al. J Manag Care Spec Pharm. 2016 Nov;22(11):1319-1329. doi: 10.18553/jmcp.2016.22.11.1319. J Manag Care Spec Pharm. 2016. PMID: 27783556 Free PMC article.

4

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data.

Brown JD, Shewale AR, Talbert JC. Brown JD, et al. J Manag Care Spec Pharm. 2017 Sep;23(9):958-967. doi: 10.18553/jmcp.2017.23.9.958. J Manag Care Spec Pharm. 2017. PMID: 28854077 Free PMC article.

5

Vena Cava Filter Retrieval Rates and Factors Associated With Retrieval in a Large US Cohort.

Brown JD, Raissi D, Han Q, Adams VR, Talbert JC. Brown JD, et al. J Am Heart Assoc. 2017 Sep 4;6(9):e006708. doi: 10.1161/JAHA.117.006708. J Am Heart Assoc. 2017. PMID: 28871041 Free PMC article.

6

Variation in the Use of Vena Cava Filters for Venous Thromboembolism in Hospitals in Kentucky.

Brown JD, Talbert JC. Brown JD, et al. JAMA Surg. 2016 Oct 1;151(10):984-986. doi: 10.1001/jamasurg.2016.1004. JAMA Surg. 2016. PMID: 27464070 Free PMC article. No abstract available.

7

Hospital Variation and Patient Characteristics Associated With Vena Cava Filter Utilization.

Brown JD, Talbert JC. Brown JD, et al. Med Care. 2017 Jan;55(1):31-36. doi: 10.1097/MLR.0000000000000599. Med Care. 2017. PMID: 27547945 Free PMC article.

8

Treatment of Opioid Use Disorder During Pregnancy May Increase Cases of Neonatal Abstinence Syndrome-Reply.

Brown JD, Talbert JC. Brown JD, et al. JAMA Pediatr. 2017 Jul 1;171(7):707-708. doi: 10.1001/jamapediatrics.2017.0863. JAMA Pediatr. 2017. PMID: 28459984 No abstract available.

9

Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.

Brown JD, Goodin AJ, Talbert JC. Brown JD, et al. J Rural Health. 2018 Dec;34(1):6-13. doi: 10.1111/jrh.12251. Epub 2017 Jul 7. J Rural Health. 2018. PMID: 28685864 Free PMC article.

10

Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.

Pauly NJ, Talbert JC, Brown J. Pauly NJ, et al. J Manag Care Spec Pharm. 2016 Jun;22(6):741-51. doi: 10.18553/jmcp.2016.22.6.741. J Manag Care Spec Pharm. 2016. PMID: 27231801 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

793 results

Search Page

Filters